Get the Stockscreener App
2.53
1.17%
-0.03
After Hours:
2.50
-0.03
-1.19%
Fractyl Health Inc stock is traded at $2.53, with a volume of 199.44K.
It is down -1.17% in the last 24 hours and down -27.71% over the past month.
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
See More
Previous Close:
$2.56
Open:
$2.6
24h Volume:
199.44K
Relative Volume:
0.56
Market Cap:
$121.74M
Revenue:
-
Net Income/Loss:
$-56.85M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-0.39%
1M Performance:
-27.71%
6M Performance:
-65.81%
1Y Performance:
+0.00%
1-Day Range:
$2.475
$2.64
1-Week Range:
$2.35
$2.64
52-Week Range:
$1.74
$13.99
Fractyl Health Inc Stock (GUTS) Company Profile
Name
Fractyl Health Inc
Sector
Industry
Phone
781-902-8800
Address
3 VAN DE GRAAFF DRIVE, BURLINGTON
Fractyl Health Inc Stock (GUTS) Latest News
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference - GlobeNewswire
Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference - StockTitan
Financial Fitness Check: Examining Fractyl Health Inc. (GUTS)’s Key Ratios - The Dwinnex
Fractyl Health Inc. (GUTS)’s stock price in review: A technical analysis - US Post News
Massachusetts Financial Services Co. MA Acquires 25,829 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Fractyl Health president sells over $188k in company stock By Investing.com - Investing.com Canada
Fractyl Health president sells over $188k in company stock - Investing.com India
Jay David Caplan Sells 65,000 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) Stock - MarketBeat
Fractyl Health president sells over $188k in company stock - Investing.com
Fractyl Health stock down 8% following $110M IPO - MSN
Fractyl Health to Participate in Upcoming September Investor Conferences - StockTitan
Fractyl Health to Participate in Upcoming September Investor Conferences - GlobeNewswire
Fractyl Health to Participate in Upcoming September Investor Conferences - Yahoo Finance
Fractyl Health, Inc. (NASDAQ:GUTS) Short Interest Down 13.2% in August - MarketBeat
Fractyl Health Inc. (GUTS) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Fractyl Health Inc. (GUTS) can make a big difference with a little luck - SETE News
Fractyl Health Inc. (GUTS) presents a great opportunity, but the stock is slightly undervalued - US Post News
Stock Performance Spotlight: Fractyl Health Inc. (GUTS) Ends the Day at 3.58, Up by 6.23 - The Dwinnex
Investing in Fractyl Health Inc. (GUTS) might be an excellent idea, but the stock is currently overvalued/undervalued - US Post News
Fractyl Health Inc. (GUTS) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Expands By 5.7% - MarketBeat
Fractyl Health Second Quarter 2024 Earnings: US$0.36 loss per share (vs US$14.56 loss in 2Q 2023) - Yahoo Finance
GUTS Stock Earnings: Fractyl Health Beats EPS for Q2 2024 - MSN
GUTSFractyl Health, Inc. Latest Stock News & Market Updates - StockTitan
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates - wallstreet:online
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates - GlobeNewswire
Fractyl Health Reports Second Quarter 2024 Financial Results and Provides Business Updates - Yahoo Finance
An analyst sees good growth prospects for Fractyl Health Inc. (GUTS) - SETE News
Fractyl Health Announces Clinical Results from German - GlobeNewswire
Fractyl says ablation provides sustained weight loss - BioWorld Online
Fractyl Health touts positive year-long weight loss results for Revita device - Yahoo Finance
Fractyl Health Inc. (GUTS) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Fractyl Health (GUTS) Set to Announce Quarterly Earnings on Wednesday - MarketBeat
Fractyl Health (GUTS) Set to Announce Quarterly Earnings on Wednesday - Defense World
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure - GlobeNewswire
Fractyl Health Announces Clinical Results from German Real-World Registry Showing Meaningful and Sustained Weight Loss for at Least One Year After a Single Revita® Endoscopic Procedure - Yahoo Finance
Fractyl Health Inc. (GUTS) receives an Outperform rating from Evercore ISI - Knox Daily
Market Momentum: Fractyl Health Inc. (GUTS) Registers a -4.44 Decrease, Closing at 2.15 - The Dwinnex
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024 - GlobeNewswire
Fractyl Health to Report Second Quarter 2024 Financial Results and Provide Business Updates on August 14, 2024 - Yahoo Finance
DexCom (NASDAQ:DXCM) & Fractyl Health (NASDAQ:GUTS) Head-To-Head Survey - Defense World
Fractyl Health Inc. (GUTS)’s highs and lows: A closer look at its stock price fluctuations - US Post News
The Significance of Moving Averages in Fractyl Health Inc. Inc. (GUTS) Price Performance - The InvestChronicle
Daily Progress: Fractyl Health Inc. (GUTS) Drop -20.45, Closing at 3.19 - The Dwinnex
Taking a Closer Look At Fractyl Health Inc. (GUTS) Following Its Recent Trade - Knox Daily
Fractyl's Revita gains FDA breakthrough status for weight maintenance By Investing.com - Investing.com Nigeria
Fractyl gets FDA breakthrough device status for Revita - MSN
Fractyl's Revita gains FDA breakthrough status for weight maintenance - Investing.com India
Fractyl's Revita gains FDA breakthrough status for weight maintenance - Investing.com
IPO Roundup: Pershing Square, Actuate Therapeutics and more (NASDAQ:GUTS) - Seeking Alpha
Fractyl Health’s Revita System Wins FDA Breakthrough Designation - TipRanks
Fractyl Health Inc Stock (GUTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):